Effect of novel mixed ETA/ETB antagonists on responses to ET-1 in human small muscular pulmonary arteries

被引:15
作者
MacLean, MR [1 ]
Docherty, CC [1 ]
McCulloch, KM [1 ]
Morecroft, I [1 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland
关键词
endothelin; endothelin receptors; human pulmonary arteries; endothelin antagonists;
D O I
10.1006/pupt.1998.0129
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective ETA and ETB receptor antagonists do not fully inhibit responses to ET-1 in human small pulmonary arteries. Here, we have compared the influence of the novel mixed ETA/ETB antagonists SB/217242, SB/234551 and SB/209670 on ET-1-mediated vasoconstriction in these vessels. ET-1 was a potent vasoconstrictor (pEC(50): 8.14+/-0.05, n=5) and the concentration-response curve to ET-1 was biphasic in nature. All three mixed antagonists (1 mu M) inhibited the responses to ET-1, abolishing the biphasic form of the concentration response curve. The order of potency was SE 209670>SB 234551 greater than or equal to SB 217242 with estimated pKb values of 8.0+/-0.20, 6.8+/-0.17 and 6.6+/-0.11 respectively (n=3-5). (C) 1998 Academic Press.
引用
收藏
页码:147 / 149
页数:3
相关论文
共 10 条
[1]  
Docherty CC, 1998, J PHARMACOL EXP THER, V284, P895
[2]  
Hay DWP, 1998, J PHARMACOL EXP THER, V284, P669
[3]  
HEATH D, 1987, BRIT HEART J, V58, P204
[4]  
HEATH D, 1993, EUR RESPIR REV, V3, P555
[5]   Endothelin-1: a mediator of pulmonary hypertension? [J].
MacLean, MR .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1998, 11 (2-3) :125-132
[6]   Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat [J].
McCulloch, KM ;
Docherty, C ;
MacLean, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (08) :1621-1630
[7]   Endothelin(B) receptor-mediated contraction in human pulmonary resistance arteries [J].
McCulloch, KM ;
Docherty, CC ;
Morecroft, I ;
MacLean, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (06) :1125-1130
[8]  
Ohlstein EH, 1996, J PHARMACOL EXP THER, V276, P609
[9]  
Ohlstein EH, 1998, J PHARMACOL EXP THER, V286, P650
[10]   SB-209670, A RATIONALLY DESIGNED POTENT NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST [J].
OHLSTEIN, EH ;
NAMBI, P ;
DOUGLAS, SA ;
EDWARDS, RM ;
GELLAI, M ;
LAGO, A ;
LEBER, JD ;
COUSINS, RD ;
GAO, AM ;
FRAZEE, JS ;
PEISHOFF, CE ;
BEAN, JW ;
EGGLESTON, DS ;
ELSHOURBAGY, NA ;
KUMAR, C ;
LEE, JA ;
YUE, TL ;
LOUDEN, C ;
BROOKS, DP ;
WEINSTOCK, J ;
FEUERSTEIN, G ;
POSTE, G ;
RUFFOLO, RR ;
GLEASON, JG ;
ELLIOTT, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) :8052-8056